Recent months have seen a renewed interest in radiopharmaceuticals, with a flurry of deals made by some of the biggest players in pharma. Consequently, supply chains have struggled to keep up with demand.
Despite concerns among drug developers, this month’s cover feature assesses why, in spite of some challenges, there are reasons for optimism as this latest surge in demand for the drug class unfolds.
Also in this issue, we take a look at how the Trump administration’s tariffs on China and the prospect for similar tariffs on countries like Canada and Mexico may affect the US clinical trial supply moving forward.
This month’s lead interview centres on how equitable care can be ensured in the cancer space.
All this and the latest pharma industry news, comment, and analysis from GlobalData.
Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.
You can also subscribe here to receive email notifications when a new issue is available.
